Skip to main content

Table 1 Baseline characteristics and participant profiles

From: Efficacy of a self-management program in patients with chronic viral hepatitis in China

Variable

Intervention group

Usual care group

p value

(n = 30)

(n = 30)

Characteristics

n (%) or

n (%) or

 

mean ± SD

mean ± SD

 

 Females

15 (50.0)

6 (20.0)

0.029a*

 Employed

25 (83.3)

22 (73.3)

0.532a

 Marital status: married

26 (86.7)

26 (86.7)

1.000a

 Living with another person

28 (93.3)

27 (90.0)

1.000a

 Age (years)

33.2 ± 7.29

36.6 ± 10.56

0.152b

Subject profiles

 Comorbidity

25 (83.3)

22 (73.3)

0.532a

 Diabetes mellitus

27 (90.0)

28 (93.3)

1.000a

 Recurrent history of liver disease in the past 2 years

19 (63.3)

14 (46.7)

0.299a

 Use of insulin

29 (96.7)

28 (93.3)

1.000a

Treatment regimen

 Antiviral medicine

11 (36.7)

9 (30.0)

0.785a

 Anti-fibrosis therapy

13 (43.3)

15 (50.0)

0.796a

 Immunotherapy

4 (13.3)

6 (20.0)

0.731a

 Liver protection therapy

27 (90.0)

28 (93.9)

1.000a

 Peg interferon

11 (36.7)

14 (46.7)

0.601a

Types of hepatitis

 Hepatitis B

26 (86.7)

26 (86.7)

1.000a

 Hepatitis C

4 (13.3)

4 (13.3)

  1. SD Standard Deviation
  2. *p <  0.05
  3. a p value is based on Pearson’s chi-square test
  4. b p value is based on t-test